X hits on this document

31 views

0 shares

0 downloads

0 comments

11 / 11

Giaccone et al

squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung: LCSG Protocol

  • 771.

    Chest 106:287S-292S, 1994

  • 33.

    Immunostimulation with intrapleural BCG

as adjuvant therapy in resected non-small cell lung cancer. The Ludwig Lung Cancer Study Group (LLCSG). Cancer 58:2411-2416, 1986

34. Bakker W, Nijhuis-Heddes JM, van der Velde EA: Post-operative intrapleural BCG in lung cancer: A 5-year follow-up report. Cancer Immu- nol Immunother 22:155-159, 1986

35. Pignon JP, Arriagada R, Ihde DC, et al: A meta-analysis of thoracic radiotherapy for small- cell lung cancer. N Engl J Med 327:1618-1624, 1992

36. Auperin A, Arriagada R, Pignon JP, et al: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collab- orative Group. N Engl J Med 341:476-484, 1999

37. Hanai N, Nakamura K, Shitara K: Recom- binant antibodies against ganglioside expressed

on tumor cells. Cancer Chemother Pharmacol 46:S13-S17, 2000

38. Scott AM, Lee FT, Hopkins W, et al: Spe- cific targeting, biodistribution, and lack of immu- nogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic mel- anoma: Results of a phase I trial. J Clin Oncol 19:3976-3987, 2001

39. Grant SC, Kostakoglu L, Kris MG, et al: Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: a pilot trial. Eur J Nucl Med 23:145-149, 1996

40. Simon T, Hero B, Faldum A, et al: Consol- idation treatment with chimeric anti-GD2- antibody ch14.18 in children older than 1 year with metastatic neuroblastoma. J Clin Oncol 22:3549-3557, 2004

41. Ragupathi G, Livingston PO, Hood C, et al: Consistent antibody response against ganglio- side GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin con-

jugate vaccine plus immunological adjuvant QS-

  • 21.

    Clin Cancer Res 9:5214-5220, 2003

  • 42.

    Niculescu-Duvaz I: Technology evaluation:

EMD-273063, EMD Lexigen. Curr Opin Mol Ther 6:559-566, 2004

43. King DM, Albertini MR, Schalch H, et al: Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients. J Clin Oncol 22: 4463-4473, 2004

44. Dickler MN, Ragupathi G, Liu NX, et al: Immunogenicity of a fucosyl-GM1-keyhole lim- pet hemocyanin conjugate vaccine in patients with small cell lung cancer. Clin Cancer Res 5:2773-2779, 1999

45. Krug LM, Ragupathi G, Hood C, et al: Vaccination of patients with small-cell lung can- cer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin. Clin Cancer Res 10:6094-6100, 2004

46. Hege KM, Carbone DP: Lung cancer vac- cines and gene therapy. Lung Cancer 41:S103- S113, 2003

6864

JOURNAL OF CLINICAL ONCOLOGY

Downloaded from jco.ascopubs.org on February 15, 2015. For personal use only. No other uses without permission. Copyright © 2005 American Society of Clinical Oncology. All rights reserved.

Document info
Document views31
Page views31
Page last viewedFri Dec 09 11:56:25 UTC 2016
Pages11
Paragraphs513
Words8777

Comments